Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
PACS Group, Inc.(PACS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PACS
11/09/2026: PACS (2-star) has a low Upturn Star Rating. Not recommended to BUY.
PACS Group, Inc. is a growing operator of post-acute care and skilled nursing facilities, utilizing a decentralized model that prioritizes local management autonomy. The company's main strength lies in its proven ability to acquire and improve the operational performance of skilled nursing facilities, capturing value through improved clinical outcomes. Its primary growth story is built on consolidating a highly fragmented industry. However, investors must monitor significant risks, including reliance on government reimbursement programs and the challenges of managing labor-intensive operations. The stock may best suit growth-oriented investors looking for exposure to the senior care sector, with the understanding that regulatory changes and integration execution remain critical developments to watch.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company is in an active expansion phase with a clear strategy to scale via acquisitions. |
| Momentum investor | Mixed fit | Momentum potential exists given the recent IPO and growth trajectory, conditional on positive technical trends. |
| Value investor | Weak fit | Current valuation reflects growth expectations rather than traditional value metrics. |
| Dividend investor | Weak fit | The company does not pay a dividend and prioritizes capital reinvestment. |
| Low-risk investor | Weak fit | Healthcare regulatory risks and high leverage make this less suitable for conservative portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | As a relatively recent IPO, the stock may experience significant price swings based on sentiment. |
| Valuation risk | Medium / high | Growth expectations are priced in, leaving little room for earnings disappointments. |
| Competition risk (nursing and facility consolidation) | Medium | The sector is fragmented, making it difficult to maintain pricing power against large incumbents. |
| Business quality | Medium | Success relies heavily on facility-level management and consistent clinical performance. |
| Dividend income | Low / none | No income is provided to shareholders. |
| Execution risk | Medium / high | Successful integration of newly acquired facilities is vital for long-term margin improvement. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -19.97% | Avg. Invested days 33 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/09/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 7.87B USD | Price to earnings Ratio 28.18 | 1Y Target Price 61.33 |
Price to earnings Ratio 28.18 | 1Y Target Price 61.33 | ||
Volume (30-day avg) 892.7K shares | Beta -0.14 | 52 Weeks Range 10.31 - 51.68 | Updated Date 11/08/2026 |
52 Weeks Range 10.31 - 51.68 | Updated Date 11/08/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.76 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Skilled Nursing | Reimbursement from Medicare and Medicaid for patient care. | The primary source of revenue comes from providing daily clinical care in nursing homes. |
| Ancillary Services | Therapy services and specialized health support. | Additional revenue is generated by providing health services within their own facilities. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-11-03 | When After Market | Estimate 0.56 | Actual 0.63 |
Profitability
Profit Margin 4.87% | Operating Margin (TTM) 6.65% |
Management Effectiveness
Return on Assets (TTM) 4.59% | Return on Equity (TTM) 26.5% |
Valuation
Trailing PE 28.18 | Forward PE 18.76 | Enterprise Value 11.16B | Price to Sales(TTM) 1.38 |
Enterprise Value 11.16B | Price to Sales(TTM) 1.38 | ||
Enterprise Value to Revenue 1.96 | Enterprise Value to EBITDA 22.44 | Shares Outstanding 158.72M | Shares Floating 50.09M |
Shares Outstanding 158.72M | Shares Floating 50.09M | ||
Percent Insiders 68.19 | Percent Institutions 32.12 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.